- Home
- SGRY vs ORIC Comparison
SGRY vs ORIC Comparison
Compare SGRY & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGRY | ORIC |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SGRY | ORIC |
|---|---|---|
| Price | $13.23 | $12.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 15 |
| Target Price | $18.82 | ★ $21.08 |
| AVG Volume (30 Days) | ★ 2.1M | 1.2M |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.14 | 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,145,438,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.41 | $7.23 |
| 52 Week High | $23.44 | $14.93 |
Technical Indicators
Market Signals| Indicator | SGRY | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 57.13 |
| Support Level | $13.26 | $13.12 |
| Resistance Level | $15.02 | $14.22 |
| Average True Range (ATR) | 0.78 | 0.69 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 32.02 | 73.36 |
Price Performance
Historical ComparisonAbout SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.